• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants

    Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants

  2. Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy

    Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy

  3. Inovio to Present at Upcoming Investor Conferences

    Inovio to Present at Upcoming Investor Conferences

  4. AstraZeneca Unit to Buy Definiens

    AstraZeneca Unit to Buy Definiens

  5. AstraZeneca Unit to Buy Privately-Held Definiens For $150 Million

    AstraZeneca Unit to Buy Privately-Held Definiens For $150 Million

  6. Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014

    Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014

  7. AstraZeneca And Pharmacyclics Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors

    AstraZeneca And Pharmacyclics Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors

  8. Morningstar Indexes: Weekly Market Report

    Week ending April 27: Quarterly earnings continue to boost market's spirits. 

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  10. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.